Site search

Amlitelimab (KY1005) for moderate to severe atopic dermatitis Research study

A clinical trial to assess a new drug called amlitelimab (KY1005) as a treatment for moderate to severe atopic dermatitis (eczema)

WVE-003 in patients with Huntington’s disease Research study

A multicentre, randomised, double-blind, placebo-controlled, phase 1b/2a study of WVE-003 in patients with Huntington’s disease.

BI 456906 for non-alcoholic steatohepatitis (NASH) and liver fibrosis Research study

A study to test whether different doses of BI 456906 are effective in people with a liver disease called non-alcoholic steatohepatitis (NASH) and liver fibrosis.

Mirikizumab for moderate to severely active Crohn’s disease Research study

A clinical trial to assess the safety and effectiveness of a new drug, mirikizumab, for moderate to severely active Crohn’s disease.

Atezolizumab plus bevacizumab for treated hepatocellular patients at high risk of recurrence Research study

A clinical trial to assess the effectiveness of a combination immunotherapy versus active surveillance for treated hepatocellular patients who are at high risk of recurrence.

New blood test to detect bowel cancer Research study

Seeking adults diagnosed with bowel cancer who will be having surgery, chemotherapy or radiation therapy in the next 30 days for a study to assess the effectiveness of a new blood test to detect bowel cancer.

New potential treatment for adult males with Tourette Syndrome Research study

A study to evaluate the safety and efficacy of new drug in male patients aged 18 to 50 with Tourette Syndrome (TS).

New blood test to diagnose and monitor autoimmune blistering skin conditions Research study

A prospective study on serum antibodies against target antigens of bullous autoimmune diseases and genetic susceptibility.

Effects of denosumab on normal breast tissue for BRCA gene carriers Research study

A trial to investigate the effects of denosumab on normal breast tissue in patients with BRCA 1 or 2 mutations and to determine if the drug has the potential to prevent breast cancer.

mRNA vaccine for preventing cytomegalovirus infection Research study

A clinical trial seeking to develop an mRNA vaccine for preventing cytomegalovirus (CMV) infection.

Understanding antigen triggers in psoriasis Research study

A non-interventional study to investigate triggers in psoriasis.

A new insulin when used in combination with oral medications to manage type 2 diabetes Research study

A clinical trial to investigate the safety and effectiveness of a new insulin (INS068) when used in combination with oral medications to manage type 2 diabetes.

Denosumab as a prevention for breast cancer in women with a BRCA1 mutation Research study

This research is to find out whether the study medication, denosumab, can help prevent breast cancer in women with a BRCA1 mutation.

Bitopertin as a treatment for erythropoietic protoporphyria Research study

Research project to measure how safe and effective bitopertin (DISC-1459) is in treating participants with erythropoietic protoporphyria.

Swabs required for research to develop point-of-care testing for infectious diseases Research study

ZiP Diagnostics requires human samples for research into developing point-of-care (PoC) diagnostic tests for a range of infectious diseases.

Benralizumab for the treatment of bullous pemphigoid Research study

A research project to measure how safe and effective benralizumab is in treating participants with bullous pemphigoid (BP).

New drug for basal cell carcinoma Research study

A study to assess the safety and efficacy of ASN-002 combined with a hedgehog pathway inhibitor (vismodegib) in the treatment of multiple low-risk basal cell carcinomas in sporadic or basal cell naevus syndrome patients.

Possible new drug for Crohn’s disease Research study

We aimed to determine the safety and effectiveness of a new study medication, guselkumab, for people with Crohn's disease

Etrasimod for the treatment of ulcerative colitis Research study

A clinical trial to assess the safety and efficacy of an oral medication called Etrasimod for moderately active ulcerative colitis (UC).

KBL697 for the treatment of ulcerative colitis Research study

Study investigated Lactobacillus gasseri in patients with mild to moderate active ulcerative colitis.